Account
Inquiry
Oral semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist widely studied for its role in weight management and type 2 diabetes treatment. This product, with a purity of 99%, is provided in lyophilized powder form and is intended solely for research purposes. It is not for personal or human consumption.
Tirzepatide, also known as LY3298176, functions as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. Research indicates that tirzepatide may offer superior efficacy in glucose control and weight reduction compared to selective GLP-1 agonists. Its mechanism involves mimicking natural GIP actions, contributing to improved metabolic outcomes in scientific studies.
Our oral semaglutide and tirzepatide products are manufactured under strict quality control to ensure high standards. Each batch is tested for purity and performance, with a Certificate of Analysis (COA) provided. The product is available in various packaging sizes to meet diverse research needs, including 10mg, 15mg, 20mg, 30mg, 40mg, and 60mg vials, packaged in boxes of 10 vials each.
Storage recommendations include refrigeration, keeping the product dry and protected from light to maintain stability over a shelf life of 2 years. This ensures the integrity of the peptide for ongoing research applications.
